NDC 63323-403-01 - Fosphenytoin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 63323-403
- Requested NDC
- 63323-403-01
- Package NDCs from labels
- 63323-403-01, 63323-403-02, 63323-403-04, 63323-403-10
- Manufacturer
- Fresenius Kabi USA, LLC
- Effective date
- 2023-03-31
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Fosphenytoin - Fresenius Kabi USA, LLC | Fresenius Kabi USA, LLC | 2023-03-31 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63323-403-01 | Fosphenytoin | 2 mL in 1 VIAL | INJECTION, SOLUTION | 2 | 14 | |
| 63323-403-02 | Fosphenytoin | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 14 | |
| 63323-403-04 | Fosphenytoin | 10 mL in 1 VIAL | INJECTION, SOLUTION | 10 | 14 | |
| 63323-403-10 | Fosphenytoin | 10 in 1 TRAY | INJECTION, SOLUTION | 10 | 14 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 63323-403-01 | ML - Milliliter | 63323-403 | 1e2e3f93-b845-42e3-819d-5d1d86109c8f | 1 | 2018-08-13 |
| 63323-403-02 | ML - Milliliter | 63323-403 | 565eaf95-6a7e-44da-950c-687bfa783865 | 1 | 2012-07-24 |
| 63323-403-04 | ML - Milliliter | 63323-403 | 5b6a304c-1805-4fca-a4eb-ab6cfe94563a | 1 | 2018-08-13 |
| 63323-403-10 | ML - Milliliter | 63323-403 | f39ee679-eb9c-426d-96bf-f1203af01838 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| FOSPHENYTOIN SODIUM | ACTIVE INGREDIENT | 7VLR55452Z | FOSPHENYTOIN (FOSPHENYTOIN SODIUM) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 6 | |
| PHENYTOIN | ACTIVE MOIETY | 6158TKW0C5 | FOSPHENYTOIN (FOSPHENYTOIN SODIUM) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 6 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | FOSPHENYTOIN (FOSPHENYTOIN SODIUM) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 6 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | FOSPHENYTOIN (FOSPHENYTOIN SODIUM) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 6 | |
| TROMETHAMINE | INACTIVE INGREDIENT | 023C2WHX2V | FOSPHENYTOIN (FOSPHENYTOIN SODIUM) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 6 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Bio Rock Water | ROCK WATER | BioActive Nutritional, Inc. | 178bd16d-0d4f-49d8-866b-8ab3a3c6889d | 2018-07-30 | Warnings | 059QF0KO0R |
| Fosphenytoin Sodium | FOSPHENYTOIN SODIUM | West-Ward Pharmaceuticals Corp | c92df63b-5140-4213-8d43-8327ff6230b7 | 2018-01-04 | Boxed warning, Warnings, Adverse reactions | 1670200 1670195 7VLR55452Z |
| Sterile Water | WATER | Baxter Healthcare Corporation | ef3e79c5-3f58-4b36-a296-64b7d9a651c1 | 2017-10-17 | Warnings, Adverse reactions | 059QF0KO0R |
| Eye Wash | WATER | CVS Pharmacy | 049cee29-7ec2-4d5b-8308-f522acde43a7 | 2017-03-29 | Warnings | 059QF0KO0R |
| Sterile Water | WATER | Baxter Healthcare Company | 210dc9ab-d6ca-4552-ac19-1be17792d290 | 2016-05-31 | Warnings, Adverse reactions | 059QF0KO0R |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.